Machatha Stephen bought ALDX
March 4, 2025 · Form 4 insider transaction
Machatha Stephen bought 202,427 shares of Aldeyra Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
202,427
Price
$0.00
Total value
N/A
InsiderMachatha Stephen
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 4, 2025
Filing dateMarch 6, 2025
Shares owned after202,427
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2025.